Uemura, Hiroji http://orcid.org/0000-0001-7943-1564
Matsushima, Hisashi
Kobayashi, Kazuki
Mizusawa, Hiroya
Nishimatsu, Hiroaki
Fizazi, Karim
Smith, Matthew
Shore, Neal
Tammela, Teuvo
Tabata, Ken-ichi
Matsubara, Nobuaki
Iinuma, Masahiro
Uemura, Hirotsugu
Oya, Mototsugu
Momma, Tetsuo
Kawakita, Mutsushi
Fukasawa, Satoshi
Kobayashi, Tadahiro
Kuss, Iris
Le Berre, Marie-Aude
Snapir, Amir
Sarapohja, Toni
Suzuki, Kazuhiro
Funding for this research was provided by:
Bayer AG
Orion Pharma
Article History
Received: 28 June 2020
Accepted: 21 October 2020
First Online: 23 November 2020
Compliance with ethical standards
:
: Hiroji Uemura has received honoraria from Bayer, Janssen, Astellas, Takeda, and AstraZeneca, and research funding from Astellas and Takeda. Hisashi Matsushima, Kazuki Kobayashi, Hiroya Mizusawa, Hiroaki Nishimatsu, Masahiro Iinuma, Tetsuo Momma, Satoshi Fukasawa, and Tadahiro Kobayashi report no conflicts of interest. Karim Fizazi has received honoraria from, and acted as a consultant for Janssen, Bayer, Astellas, Sanofi, Orion, Curvec, AstraZeneca, Essa, Amgen, and Roche, and has received accommodation or travel expenses from Amgen and Janssen. Matthew Smith has received honoraria from and acted as a consultant for, Amgen, Astellas, Bayer, Clovis, Gilead, Janssen, Eli Lilly, Novartis, and Pfizer. Neal Shore has acted as a consultant for Bayer, Janssen, Tolmar, Ferring, Medivation, Amgen, Pfizer, AstraZeneca, Genentech/Roche, Myovant Sciences, Astellas Pharma, Merck, and Dendreon, and has received honoraria from Bayer, Janssen, Tolmar, Ferring, Medivation, Amgen, Pfizer, AstraZeneca, Genentech/Roche, Myovant Sciences, Astellas Pharma, Merck. Teuvo Tammela has received honoraria from Janssen, and research funding from Bayer, Lidds AB, and Astellas Pharma. Ken-ichi Tabata has received honoraria from Janssen. Nobuaki Matsubara has received honoraria from Chugai Pharmaceutical, MSD, Bayer, Sanofi, and Janssen, and research funding from Chugai Pharmaceutical, MSD, Bayer, Janssen, Astellas, AstraZeneca, Taiho Pharmaceutical, and Pfizer. Hirotsugu Uemura has acted as an advisor for Bayer, Janssen, and Sanofi; has received honoraria from Astellas, AstraZeneca, Bayer, Janssen, MSD, Sanofi, and Takeda; and has received research funding from Astellas, AstraZeneca, Janssen, Ono, Sanofi, Taiho, and Takeda. Mototsugu Oya has received honoraria from Astellas, Sanofi, Janssen, AstraZeneca, and Takeda, and research funding from Astellas. Mutsushi Kawakita has acted as an advisor for Medicaroid Corporation. Iris Kuss is an employee of and holds stocks in Bayer AG. Marie-Aude Le Berre is an employee of Bayer HealthCare. Amir Snapir was an employee of Orion Pharma and is currently an employee of PCI Biotech. Toni Sarapohja is an employee of Orion Pharma. Kazuhiro Suzuki has received honoraria from Bayer, Takeda, Astellas, Daiichi-Sankyo, AstraZeneca, Janssen, and Sanofi, and has received research funding from Takeda, Astellas, Daiichi-Sankyo.